In this review:
SC vs IV daratumumab RRMM
Pomalidomide/dexamethasone ± isatuximab in RRMM
VTD ± daratumumab in transplant-eligible newly diagnosed MM
Blinatumomab for MRD in B-cell precursor ALL: final OS from BLAST
Gilteritinib prolongs OS in FLT3-mutated R/R AML
PET-driven radiotherapy for low risk DLBCL
Ibrutinib in asymptomatic, treatment-naïve, early-stageCLL
Curative strategy for high-risk smouldering myeloma
HOPE trial: voxelotor in sickle cell disease
Inhibition of complement C1s in cold agglutinin disease
Please login below to download this issue (PDF)